These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6326629)

  • 1. Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition.
    Packer M; Medina N; Yushak M
    Ann Intern Med; 1984 Jun; 100(6):782-9. PubMed ID: 6326629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1984 Apr; 3(4):1035-43. PubMed ID: 6323565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congestive heart failure.
    Ruggie N
    Med Clin North Am; 1986 Jul; 70(4):829-51. PubMed ID: 3012226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure.
    Packer M; Lee WH; Kessler PD; Medina N; Yushak M; Gottlieb SS
    J Am Coll Cardiol; 1987 Oct; 10(4):837-44. PubMed ID: 2821091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilator therapy of severe congestive heart failure: the special importance of angiotensin-converting enzyme inhibition with captopril.
    Awan NA; Mason DT
    Am Heart J; 1982 Nov; 104(5 Pt 2):1127-36. PubMed ID: 6291358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of hyponatremia with angiotensin-converting enzyme inhibitors in patients with congestive heart failure.
    Elisaf M; Theodorou J; Pappas C; Siamopoulos K
    Cardiology; 1995; 86(6):477-80. PubMed ID: 7585758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.
    Packer M; Lee WH; Medina N; Yushak M; Kessler PD; Gottlieb SS
    Am J Med; 1987 Jun; 82(6):1119-26. PubMed ID: 3037896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
    Rouleau JL; Chatterjee K; Benge W; Parmley WW; Hiramatsu B
    Circulation; 1982 Apr; 65(4):671-8. PubMed ID: 7037220
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia.
    Dzau VJ; Hollenberg NK
    Ann Intern Med; 1984 Jun; 100(6):777-82. PubMed ID: 6372563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alternatives to digitalis therapy].
    Larbig D; Nasse H
    Dtsch Med Wochenschr; 1983 Nov; 108(45):1725-9. PubMed ID: 6354664
    [No Abstract]   [Full Text] [Related]  

  • 13. Captopril in congestive heart failure: improved left ventricular function with decreased metabolic cost.
    Chatterjee K; Rouleau JL; Parmley WW
    Am Heart J; 1982 Nov; 104(5 Pt 2):1137-46. PubMed ID: 6291359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of amrinone-hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure.
    Siegel LA; Keung E; Siskind SJ; Forman R; Feinberg H; Strom J; Efstathakis D; Sonnenblick EH; LeJemtel TH
    Circulation; 1981 Apr; 63(4):838-44. PubMed ID: 7471340
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial.
    Fonarow GC; Chelimsky-Fallick C; Stevenson LW; Luu M; Hamilton MA; Moriguchi JD; Tillisch JH; Walden JA; Albanese E
    J Am Coll Cardiol; 1992 Mar; 19(4):842-50. PubMed ID: 1545080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
    Sharpe DN; Coxon R
    Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade.
    Kugler J; Maskin CS; Frishman W; Sonnenblick EH; LeJemtel TH
    Am Heart J; 1982 Nov; 104(5 Pt 2):1154-9. PubMed ID: 6127943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
    Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
    Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic.
    Packer M
    Int J Cardiol; 1985 Feb; 7(2):111-20. PubMed ID: 2982750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.